Kaisa Ahopelto1,2, Camilla Böckelman2,3, Jaana Hagström2,4, Selja Koskensalo1,2, Caj Haglund1,2. 1. a Department of Surgery , University of Helsinki and Helsinki University Hospital , Helsinki , Finland. 2. b Research Programs Unit, Translational Cancer Biology, University of Helsinki , Helsinki , Finland. 3. c Department of Surgery , Vaasa Central Hospital , Vaasa , Finland. 4. d Department of Pathology and Oral Pathology , University of Helsinki and Helsinki University Hospital , Helsinki , Finland.
Abstract
BACKGROUND: Transketolase-like protein 1 (TKTL1) is an isoform of tranketolase, a key protein in a cancer cell's glucose metabolism that causes rapid cell growth and controls the non-oxidative part of the pentose phosphate pathway (PPP). Its overexpression occurs in several human cancer types. Our purpose was to study whether TKTL1 expression in colorectal cancer tissue associates with these patients' prognosis. METHODS: We collected retrospectively patient data and tissue samples from 840 colorectal cancer patients treated at Helsinki University Hospital, then stained tumor tissue microarrays for TKTL1 by immunohistochemistry, and compared immunohistochemical tissue expression with clinico-pathological parameters and survival. RESULTS: High expression of TKTL1 associated with high Dukes stage, non-mucinous adenocarcinoma, and left-sided disease. Patients with high TKTL1 expression had poorer prognosis than those with low expression, with a 5-year disease-specific survival of 55.7% vs. 62.7%. CONCLUSION: We show that high TKTL1 in tumor tissue can lead to poor survival in colorectal cancer. TKTL1 thus can serve as a candidate marker for identifying patients at risk of recurrent disease.
BACKGROUND:Transketolase-like protein 1 (TKTL1) is an isoform of tranketolase, a key protein in a cancer cell's glucose metabolism that causes rapid cell growth and controls the non-oxidative part of the pentose phosphate pathway (PPP). Its overexpression occurs in several humancancer types. Our purpose was to study whether TKTL1 expression in colorectal cancer tissue associates with these patients' prognosis. METHODS: We collected retrospectively patient data and tissue samples from 840 colorectal cancerpatients treated at Helsinki University Hospital, then stained tumor tissue microarrays for TKTL1 by immunohistochemistry, and compared immunohistochemical tissue expression with clinico-pathological parameters and survival. RESULTS: High expression of TKTL1 associated with high Dukes stage, non-mucinous adenocarcinoma, and left-sided disease. Patients with high TKTL1 expression had poorer prognosis than those with low expression, with a 5-year disease-specific survival of 55.7% vs. 62.7%. CONCLUSION: We show that high TKTL1 in tumor tissue can lead to poor survival in colorectal cancer. TKTL1 thus can serve as a candidate marker for identifying patients at risk of recurrent disease.
Authors: Martin Grimm; Sebastian Hoefert; Oliver Luz; Siegmar Reinert; Joachim Polligkeit Journal: Oral Surg Oral Med Oral Pathol Oral Radiol Date: 2012-07-21
Authors: Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray Journal: Int J Cancer Date: 2014-10-09 Impact factor: 7.396
Authors: Wenyue Sun; Yan Liu; Chad A Glazer; Chunbo Shao; Sheetal Bhan; Semra Demokan; Ming Zhao; Michelle A Rudek; Patrick K Ha; Joseph A Califano Journal: Clin Cancer Res Date: 2010-01-26 Impact factor: 12.531
Authors: Santiago Diaz-Moralli; Miriam Tarrado-Castellarnau; Cristina Alenda; Antoni Castells; Marta Cascante Journal: PLoS One Date: 2011-09-27 Impact factor: 3.240
Authors: S Langbein; M Zerilli; A Zur Hausen; W Staiger; K Rensch-Boschert; N Lukan; J Popa; M P Ternullo; A Steidler; C Weiss; R Grobholz; F Willeke; P Alken; G Stassi; P Schubert; J F Coy Journal: Br J Cancer Date: 2006-02-27 Impact factor: 7.640
Authors: Igor Tsaur; Kristina Thurn; Eva Juengel; Elsie Oppermann; Karen Nelson; Christian Thomas; Georg Bartsch; Gerhard M Oremek; Axel Haferkamp; Peter Rubenwolf; Roman A Blaheta Journal: Cent European J Urol Date: 2016-06-30
Authors: Zhaoming Wang; Katherine A McGlynn; Ewa Rajpert-De Meyts; D Timothy Bishop; Charles C Chung; Marlene D Dalgaard; Mark H Greene; Ramneek Gupta; Tom Grotmol; Trine B Haugen; Robert Karlsson; Kevin Litchfield; Nandita Mitra; Kasper Nielsen; Louise C Pyle; Stephen M Schwartz; Vésteinn Thorsson; Saran Vardhanabhuti; Fredrik Wiklund; Clare Turnbull; Stephen J Chanock; Peter A Kanetsky; Katherine L Nathanson Journal: Nat Genet Date: 2017-06-12 Impact factor: 38.330